BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
DRUG on Nasdaq
Shares outstanding
7,758,356
Price per share
$85.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,587,306
Total reported value
$514,691,301
% of total 13F portfolios
0%
Share change
+525,637
Value change
+$43,107,109
Number of holders
73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 15% -8.8% $103,357,513 +$924,052 1,155,995 +0.9% JANUS HENDERSON GROUP PLC 31 Dec 2025
Cormorant Asset Management, LP 11% $82,670,191 1,059,331 Cormorant Asset Management, LP 31 Jan 2026
Vivo Opportunity Fund Holdings, L.P. 6.4% $27,550,801 454,184 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
PERCEPTIVE ADVISORS LLC 4.6% -28% $40,171,019 +$414,952 449,290 +1% Perceptive Advisors LLC 31 Dec 2025
Adage Capital Management, L.P. 5.6% $24,005,770 395,743 Adage Capital Management, L.P. 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 2.9% $6,376,530 206,427 RA Capital Management, L.P. 31 Mar 2025
Sio Capital Management, LLC 2.7% -65% $11,571,744 -$19,506,679 190,764 -63% Sio Capital Management, LLC 30 Sep 2025
Point72 Asset Management, L.P. 3% $4,175,988 135,189 Point72 Asset Management, L.P. 31 Dec 2024
Commodore Capital LP 0.3% -99% $1,685,468 -$43,019,532 18,851 -96% Commodore Capital LP 31 Dec 2025

As of 31 Dec 2025, 73 institutional investors reported holding 6,587,306 shares of BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG). This represents 85% of the company’s total 7,758,356 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 15% 1,155,995 +0.9% 0.04% $90,832,307
Cormorant Asset Management, LP 14% 1,059,331 0% 4.7% $82,670,191
Vivo Capital, LLC 6.5% 501,617 0% 2.5% $39,146,191
PERCEPTIVE ADVISORS LLC 5.8% 449,290 0% 0.64% $35,062,592
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.1% 395,743 0% 0.05% $30,883,784
BlackRock, Inc. 5.1% 394,043 +68% 0% $30,751,116
BRAIDWELL LP 4.2% 324,358 +6.8% 0.81% $25,312,898
Driehaus Capital Management LLC 3.5% 269,641 0.14% $21,042,784
MPM BIOIMPACT LLC 3% 230,147 2.1% $17,960,672
Balyasny Asset Management L.P. 2.9% 225,412 +21% 0.03% $17,591,152
MILLENNIUM MANAGEMENT LLC 2.5% 194,437 +154% 0.01% $15,173,863
Ikarian Capital, LLC 2.1% 159,421 +933% 1.6% $12,441,215
MORGAN STANLEY 1.7% 132,122 -31% 0% $10,310,878
EVENTIDE ASSET MANAGEMENT, LLC 1.3% 103,013 0.13% $8,039,135
STEMPOINT CAPITAL LP 1.3% 97,340 1.3% $7,596,414
ACUTA CAPITAL PARTNERS, LLC 1.1% 84,477 -0.47% 4.5% $6,592,585
Sio Capital Management, LLC 1.1% 81,883 -57% 1.1% $6,390,149
STATE STREET CORP 1% 77,278 +13% 0% $6,030,775
GEODE CAPITAL MANAGEMENT, LLC 0.82% 63,546 +9.8% 0% $4,959,129
SEVEN GRAND MANAGERS, LLC 0.64% 50,000 0.3% $3,902,000
VANGUARD GROUP INC 0.63% 48,576 +7.7% 0% $3,790,871
GOLDMAN SACHS GROUP INC 0.63% 48,547 0% $3,788,608
BOOTHBAY FUND MANAGEMENT, LLC 0.61% 47,490 +69% 0.1% $3,706,120
SUPERSTRING CAPITAL MANAGEMENT LP 0.61% 47,278 -12% 2% $3,689,575
Artia Global Partners LP 0.43% 33,407 0.42% $2,607,082

Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,587,306 $514,691,301 +$43,107,109 $78.04 73
2025 Q3 6,040,789 $366,118,700 +$48,861,748 $60.66 63
2025 Q2 5,234,387 $136,973,710 -$2,453,899 $26.11 46
2025 Q1 5,217,399 $188,361,504 +$11,625,261 $36.07 34
2024 Q4 4,897,032 $176,406,965 +$167,324,812 $36.02 31
2024 Q3 191,547 $229,810 -$6,160 $1.17 6
2024 Q2 197,030 $207,191 -$19,280 $1.05 5
2024 Q1 213,375 $255,563 -$27,190 $1.20 7
2023 Q4 228,082 $329,806 +$48,212 $1.43 7
2023 Q3 194,505 $309,171 +$309,171 $1.60 5